Resumen:
he aim of this work was to predict the permeability of two model drugs, sulfamerazine (SMR) and indomethacin (INM), and to determine the effect on their apparent permeabilities by complexation with cyclodextrins and/or meglumine or incorporation in microemulsions. Permeation experiments were performed using two-chamber diffusion cells with a new composition of bio-mimetic membrane composed of an 80% of Lipoid® S100 and a 20% of cholesterol in n-octanol 10% w/w solution, at 37 ± 0.50C and 14000 rpm. The predictive capacity of the permeability of passive diffusion absorbed compounds was evaluated using 20 drug standards, and showed an exponential correlation between the apparent permeability coefficients (Papp) and the fraction absorbed percentages in humans (Fa%), with an R square value of 0.67942 and a constant value of -4.1 ± 0.8. SMR and INM, were classified as CLASS II, according to the Biopharmaceutical Classification System (BCS). These drugs, were complexed and incorporated i